+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Gadobutrol"

From
Contrast Media Injectors Market Report 2025 - Product Thumbnail Image

Contrast Media Injectors Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
From
  • 5 Results (Page 1 of 1)
Loading Indicator

Gadobutrol is a type of contrast media used in medical imaging. It is a gadolinium-based contrast agent, which is injected into the body to improve the visibility of organs and tissues during magnetic resonance imaging (MRI) scans. Gadobutrol is used to enhance the contrast between normal and abnormal tissues, allowing for more accurate diagnosis. It is also used to detect and monitor certain diseases, such as cancer, and to evaluate the effectiveness of treatments. Gadobutrol is available in a variety of formulations, including liquid and powder forms. It is typically administered intravenously, but can also be administered orally or rectally. The safety and efficacy of gadobutrol have been established in clinical trials, and it is approved for use in many countries. Gadobutrol is manufactured by several companies, including Bayer, Bracco, Guerbet, and Mallinckrodt. It is available in a variety of formulations, including liquid and powder forms. Show Less Read more